Page last updated: 2024-08-22

molybdenum and Neoplasms

molybdenum has been researched along with Neoplasms in 108 studies

Research

Studies (108)

Timeframe	Studies, this research(%)	All Research%
pre-1990	11 (10.19)	18.7374
1990's	3 (2.78)	18.2507
2000's	20 (18.52)	29.6817
2010's	39 (36.11)	24.3611
2020's	35 (32.41)	2.80

Authors

Authors	Studies
Du, L; Gao, F; Jiang, Y; Li, H; Li, J; Sun, Z; Tong, Y; Wang, C; Zhao, L	1
Guo, Y; Shi, J; Yang, B; Yang, J; Yao, H	1
Li, J; Lu, C; Xie, M; Yang, M; Yang, N	1
Li, J; Li, Z; Wang, S; Wu, H; Zhang, J; Zhang, L; Zhang, Y; Zhao, J; Zhao, Y; Zou, D	1
Chen, H; Guo, Y; Guo, Z; Lan, P; Li, M; Li, Y; Liu, Z; Zhang, Y; Zheng, Y	1
Ma, X; Qi, Y; Qian, Z; Song, Y; Yuan, W; Yuan, Y	1
Cao, G; Gao, D; He, Y; Ma, Z; Ni, S; Tang, Y; Wang, D; Wang, J; Xu, Z; Yuan, Y	1
Cai, HL; Lv, Z; Song, R; Song, X; Tang, W; Wang, Y; Wei, J; Wu, XS; Wu, Y; Yang, D; Zhang, A; Zhong, W; Zhou, X	1
Cheng, L; Cheng, S; Gong, F; Han, Z; Lei, H; Liu, Z; Wang, L; Wang, T; Wang, Y; Yang, N; Yang, X; Zhou, Y	1
Deshpande, UP; Kakati, M; Murty, US; Pemmaraju, DB; Phukan, S; Rahman, M; Sathe, V	1
Liu, J; Smith, S; Wang, C	1
Chen, J; Chen, Y; Feng, W; Xia, L; Xia, W; Xie, Y; Zhang, S	1
Guo, J; Huang, Z; Liu, H; Pan, X; Shi, R; Wu, Q; Xue, Y; Zhang, H; Zhang, J	1
Deng, L; Li, Y; Liu, H; Wang, K; Wang, L; Yan, J; Zhang, G	1
Dolati, A; Karimi, M; Kiani, J; Madjd, Z; Naseri, N; Ranjbar, S; Saeedi, S; Vojgani, Y	1
Bai, Q; Lin, H; Liu, J; Qu, F; Sun, X; Wang, M; Yang, P	1
Cheng, L; Huang, Y; Lai, Z; Liu, T; Liu, Z; Shen, S; Tran, TH; Zhang, X	1
Liu, X; Qu, X; Ren, J; Wu, S	1
Cheng, J; Deng, T; Feng, C; Li, Y; Xie, M; Yang, M; Yang, N	1
Cai, L; Dong, L; Li, J; Wang, Q; Wang, Y; Xu, K; Zhao, M	1
Annušová, A; Benkovičová, M; Bodík, M; Jergel, M; Kálosi, A; Kasak, P; Kollár, J; Kotlár, M; Labudová, M; Majkova, E; Pastoreková, S; Siffalovic, P	1
Han, Y; Li, J; Li, W; Peng, X; Qu, B; Zhang, R; Zhang, X	1
Cai, L; Chen, M; Dong, L; Li, J; Lu, J; Wang, Q; Zhao, M	1
Cheng, J; Li, J; Shi, J; Wang, Y; Zhang, CY	1
Rieber, M	1
Chen, Y; Li, J; Liu, X; Liu, Y; Wang, S; Zhang, J; Zhao, J; Zheng, Y; Zhou, L	1
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J	1
Chen, G; Dong, S; Dong, Y; Feng, L; He, F; Li, W; Liu, S; Sun, Q; Wang, Z; Yang, P	1
Du, X; Hu, J; Li, X; Zhang, C	1
Bangar, P; Chaudhari, P; Dhas, N; Garg, N; Garkal, A; Ghate, V; Khot, S; Kudarha, R; Lewis, S; Mehta, T; Panzade, P; Paryani, M; Sharma, S; Singh, A; Singh, N	1
Chen, L; Fu, L; He, C; Kang, L; Li, D; Li, M; Yang, S; You, Y; You, Z; Zhou, X	1
Lin, K; Wang, S; Wu, H; Yin, Y; Zhang, Z; Zhao, J	1
Moniri, E; Panahi, HA; Soltani, ER; Tahvildari, K	1
Jiang, C; Lu, L; Sun, W; Wang, W; Yu, B	1
Feng, W; Li, F; Li, L; Liu, Y; Ma, L; Wei, Z; Zhou, J; Zhu, X	1
Fan, Y; Hu, W; Li, D; Li, Y; Shen, M; Shi, X; Wang, X; Xiao, T; Xing, L	1
Adeli, M; Haag, R; Nie, C; Pan, Y; Xu, S; Zhong, Y	1
Cheng, SX; Peng, MY; Wang, SB; Zhang, XZ; Zheng, DW	1
Benbrahim-Tallaa, L; Bouvard, V; El Ghissassi, F; Grosse, Y; Guha, N; Guyton, KZ; Loomis, D; Muller, K; Straif, K; Vilahur, N	1
Cai, S; Han, Q; Jia, X; Liang, W; Qin, Y; Wang, C; Wang, X; Yang, R	1
Bharwani, Z; Chen, S; Farokhzad, OC; Guo, Z; Islam, MA; Ji, X; Li, Z; Saw, PE; Shi, J; Tao, W; Xu, X; Zhang, H	1
He, G; Li, B; Lu, X; Parkin, IP; Wang, FR; Wang, X; Wu, X; Xu, R	1
Jay, M; Kim, J; Lu, X; Narayan, RJ	1
Barrett, A; Bharwani, Z; Cai, T; Chen, H; Chen, Y; Ding, L; Farokhzad, OC; Gan, T; Ji, X; Kong, N; Li, Y; Mahmoudi, M; Tao, W; Xu, X; Zhu, X	1
Aureliano, M; Bijelic, A; Rompel, A	1
Cheng, L; Gong, F; Jin, Q; Li, Y; Liu, Z; Tian, L; Wang, M; Yang, N	1
Adawi, AM; Bouillard, JG; Efremova, OA; Eling, CJ; Eltsov, IV; Evtushok, DV; Fufaeva, MS; Ivanov, AA; Kuratieva, NV; Mironov, YV; Miroshnichenko, SM; Pozmogova, TN; Shestopalov, MA; Shestopalova, LV; Solovieva, AO; Svezhentseva, EV; Vorotnikov, YA; Yanshole, VV	1
Chung, K; Kim, DH; Lee, H; Lim, JW; Maji, SK; Sekkarapatti Ramasamy, M; Wang, J; Yu, S	1
Cui, F; Ding, H; Ji, J; Lu, Y; Sun, J; Sun, X; Wang, H; Wang, J; Xu, D; Zhang, Y	1
Chen, W; Fang, T; Huang, G; Li, G; Liu, Y; Sheng, Y; Su, J; Tang, Q; Yuan, S; Zang, J; Zhang, X	1
Cheng, Y; Li, N; Li, P; Liu, L; Lu, Q; Song, Y; Tan, F; Wang, S; Wang, Y; Yang, L; Yang, S	1
Jia, J; Luo, Z; Su, G; Yan, B; Yue, T; Zhou, X	1
Bian, F; Cai, L; Sun, L; Wang, S; Wang, Y; Zhao, Y; Zhou, M	1
Jia, L; Li, B; Li, F; Liu, J; Zhang, D; Zheng, J	1
Liu, J; Qu, Y; Tian, Y; Zheng, T	1
An, L; Chen, Z; Hu, J; Hu, R; Jiang, F; Li, W; Qin, Z; Shen, J; Song, G; Zou, R	1
Adam, J; Kadeřávek, J; Kužel, F; Rehák, Z; Vašina, J	1
Brewer, GJ	4
Chng, EL; Pumera, M; Sofer, Z	1
Galani, A; Karaliota, A; Psycharis, V; Raptopoulou, CP; Stellas, D; Tsitsias, V	1
An, X; Cai, X; Chen, H; Chen, Y; Gao, W; Li, X; Shi, J; Wang, S; Yao, H; Zheng, Y	1
Bao, T; Dong, X; Gu, Z; Ma, X; Tian, G; Wang, Z; Yin, W; Yu, J; Zhang, X; Zhao, Y; Zheng, X	1
Du, D; Lin, Y; Yang, G; Zhu, C; Zhu, J	1
He, Y; Li, J; Liu, Y	1
Chen, H; Chen, Y; Gao, W; Li, X; Liu, J; Shi, J; Wang, S; Zhang, L; Zheng, Y	1
Abelman, S; Kim, KK; Moore, RG; Ribeiro, JR; Singh, RK; Tipping, M; Yano, N	1
Bao, T; Dong, X; Gao, F; Gu, Z; Yan, L; Yin, W; Yong, Y; Yu, J; Zhang, X; Zhao, Y; Zheng, X	1
Luo, Z; Shan, J; Teng, Z; Wang, L; Weng, L; Yuwen, L; Zhang, Q; Zhang, Y; Zhou, J	1
Deivasigamani, A; Han, J; Hui, KM; Kang, Y; Kong, SN; Wu, Y; Xia, H; Xu, R	1
Adams, A; Donate, F; Fisher, N; Harris, AL; Hayward, C; Joel, S; Lowndes, SA; Mazar, A; Middleton, M; Reich, S; Smythe, J; Timms, A; Watt, SM	1
Abnet, CC; Dawsey, SM; Dong, ZW; Fan, JH; Gail, MH; Johnson, LL; Kamangar, F; Mark, SD; Qiao, YL; Sun, XD; Taylor, PR; Yu, B	1
Khan, G; Merajver, S	1
Hanahan, D; Ishida, S; McCormick, F; Smith-McCune, K	1
Almeida, J; Bandarra, D; Brandão, P; Calhorda, MJ; Félix, V; Lopes, M; Lopes, T; Meireles, M; Nunes, CD; Saraiva, MS; Vasconcellos-Dias, M; Vaz, PD	1
Silari, M	1
Alvarez-Breckenridge, CA; Bratasz, A; Chiocca, EA; Glorioso, JC; Haseley, A; Kaka, A; Kaur, B; Mazar, AP; Old, M; Powell, K; Pradarelli, J; Teknos, TN; Wojton, J; Yoo, JY; Yu, JG	1
Suttle, NF	1
Brechbiel, M; Camphausen, K; Sproull, M	1
PINSENT, J	1
MUKHERJEE, HN	4
ARCHAMBAULT, M; SORENSEN, LB	1
Brewer, GJ; Merajver, SD	1
Harris, ED	1
Brewer, GJ; Goodman, VL; Merajver, SD	2
Hasenknopf, B	1
Bu, H; Sun, X	1
Eriguchi, M; Hisa, T; Mitsui, S; Ogata, A; Yamase, T; Yanagie, H	1
Harris, AL; Lowndes, SA	1
Brewer, GJ; Dick, R; Hou, G; Zeng, C	1
Sorenson, JR; Wangila, GW	1
Khan, GN; Merajver, SD	1
Sardesai, VM	1
Brewer, GJ; Dick, RD; Grover, DK; Jahan, T; LeCarpentier, G; LeClaire, V; Merajver, SD; Pienta, K; Redman, BG; Sondak, VK; Strawderman, M; Tseng, M; Wicha, M	1
Vanchieri, C	1
Boone, CW; Fay, JR; Kelloff, GJ; Malone, WF; Sigman, CC	1
Duch, DS; Nichol, CA; Smith, GK	1
Owen, AG; Owen, LN	1
Deelstra, H; Robberecht, H; Roekens, E	1
Allaway, WH	1
Krzymień, H	1

Reviews

25 review(s) available for molybdenum and Neoplasms

Article	Year
Molybdenum disulfide nanosheets: From exfoliation preparation to biosensing and cancer therapy applications. Colloids and surfaces. B, Biointerfaces, 2020, Volume: 194 Topics: Biosensing Techniques; Disulfides; Humans; Molybdenum; Nanostructures; Neoplasms	2020
Recent advances in MoS Journal of materials chemistry. B, 2020, 07-15, Volume: 8, Issue:27 Topics: Animals; Anti-Infective Agents; Antineoplastic Agents; Contrast Media; Disulfides; Humans; Immunotherapy; Infections; Molybdenum; Neoplasms; Photothermal Therapy	2020
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors. Annales medico-psychologiques, 2021, Volume: 179, Issue:2 Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses	2021
Molybdenum-based hetero-nanocomposites for cancer therapy, diagnosis and biosensing application: Current advancement and future breakthroughs. Journal of controlled release : official journal of the Controlled Release Society, 2021, 02-10, Volume: 330 Topics: Disulfides; Humans; Immunotherapy; Molybdenum; Nanocomposites; Neoplasms; Phototherapy	2021
Polyoxometalates as Potential Next-Generation Metallodrugs in the Combat Against Cancer. Angewandte Chemie (International ed. in English), 2019, 03-04, Volume: 58, Issue:10 Topics: Animals; Antineoplastic Agents; Drug Discovery; Humans; Models, Molecular; Molybdenum; Neoplasms; Niobium; Organometallic Compounds; Tungsten; Tungsten Compounds; Vanadium	2019
The promise of copper lowering therapy with tetrathiomolybdate in the cure of cancer and in the treatment of inflammatory disease. Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS), 2014, Volume: 28, Issue:4 Topics: Animals; Clinical Trials as Topic; Copper; Dogs; Humans; Inflammation; Molybdenum; Neoplasms; Osteosarcoma	2014
Copper chelation in cancer therapy using tetrathiomolybdate: an evolving paradigm. Expert opinion on investigational drugs, 2009, Volume: 18, Issue:4 Topics: Animals; Antineoplastic Agents; Chelating Agents; Copper; Hepatolenticular Degeneration; Humans; Molybdenum; Neoplasms	2009
Applications of particle accelerators in medicine. Radiation protection dosimetry, 2011, Volume: 146, Issue:4 Topics: Carbon; Electrons; Humans; Ions; Molybdenum; Neoplasms; Particle Accelerators; Proton Therapy; Radioisotopes; Radiotherapy, High-Energy	2011
Copper imbalances in ruminants and humans: unexpected common ground. Advances in nutrition (Bethesda, Md.), 2012, Sep-01, Volume: 3, Issue:5 Topics: Alzheimer Disease; Animals; Chelating Agents; Copper; Deficiency Diseases; Enzyme Inhibitors; Hepatolenticular Degeneration; Humans; Infections; Inflammation; Molybdenum; Neoplasms; Nutritional Requirements; Ruminants	2012
Antiangiogenic therapy through copper chelation. Expert opinion on therapeutic targets, 2003, Volume: 7, Issue:3 Topics: Angiogenesis Inhibitors; Animals; Chelating Agents; Chelation Therapy; Copper; Corneal Neovascularization; Cyclohexylamines; Hepatolenticular Degeneration; Humans; Molybdenum; Neoplasms; Neovascularization, Pathologic; Penicillamine; Pyridines; Rabbits; Trientine	2003
Cancer therapy with tetrathiomolybdate: antiangiogenesis by lowering body copper--a review. Integrative cancer therapies, 2002, Volume: 1, Issue:4 Topics: Angiogenesis Inhibitors; Animals; Chelating Agents; Copper; Humans; Molybdenum; Neoplasms	2002
A requirement for copper in angiogenesis. Nutrition reviews, 2004, Volume: 62, Issue:2 Topics: Animals; Apoptosis; Cell Division; Chelating Agents; Copper; Cornea; Growth Substances; Humans; Molybdenum; Neoplasms; Neovascularization, Pathologic; Nutritional Requirements	2004
Copper deficiency as an anti-cancer strategy. Endocrine-related cancer, 2004, Volume: 11, Issue:2 Topics: Angiogenesis Inhibitors; Animals; Chelating Agents; Copper; Humans; Molybdenum; Neoplasms; Neovascularization, Pathologic	2004
Polyoxometalates: introduction to a class of inorganic compounds and their biomedical applications. Frontiers in bioscience : a journal and virtual library, 2005, Jan-01, Volume: 10 Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Antiviral Agents; Cations; Diabetes Mellitus; Humans; Infections; Inorganic Chemicals; Metals; Molybdenum; Neoplasms; Tungsten; Vanadates	2005
Copper lowering therapy with tetrathiomolybdate as an antiangiogenic strategy in cancer. Current cancer drug targets, 2005, Volume: 5, Issue:3 Topics: Angiogenesis Inhibitors; Animals; Copper; Humans; Molybdenum; Neoplasms	2005
Anticopper therapy against cancer and diseases of inflammation and fibrosis. Drug discovery today, 2005, Aug-15, Volume: 10, Issue:16 Topics: Animals; Copper; Fibrosis; Humans; Inflammation; Molybdenum; Neoplasms; Neovascularization, Pathologic; Penicillamine; Trientine	2005
Control of copper status for cancer therapy. Current cancer drug targets, 2005, Volume: 5, Issue:7 Topics: Angiogenesis Inhibitors; Animals; Chelating Agents; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Copper; Humans; Molybdenum; Neoplasms	2005
Anticancer activity of polyoxomolybdate. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2006, Volume: 60, Issue:7 Topics: Animals; Antineoplastic Agents; Humans; Molybdenum; Neoplasms; Oxides	2006
The role of copper in tumour angiogenesis. Journal of mammary gland biology and neoplasia, 2005, Volume: 10, Issue:4 Topics: Animals; Biological Transport; Copper; Disease Models, Animal; Endothelial Cells; Humans; Models, Biological; Models, Chemical; Molybdenum; Neoplasms; Neovascularization, Pathologic; Prognosis; Up-Regulation	2005
Co-treatment with copper compounds dramatically decreases toxicities observed with cisplatin cancer therapy and the anticancer efficacy of some copper chelates supports the conclusion that copper chelate therapy may be markedly more effective and less tox Current medicinal chemistry, 2007, Volume: 14, Issue:14 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Chelating Agents; Cisplatin; Copper; Humans; Molybdenum; Neoplasms; Organometallic Compounds	2007
Modulation of angiogenesis for cancer prevention: strategies based on antioxidants and copper deficiency. Current pharmaceutical design, 2007, Volume: 13, Issue:35 Topics: Angiogenesis Inhibitors; Animals; Anticarcinogenic Agents; Antioxidants; Breast Neoplasms; Carotenoids; Cell Transformation, Neoplastic; Chelating Agents; Copper; Dietary Supplements; Female; Flavonoids; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Molybdenum; Neoplasms; Neovascularization, Pathologic; NF-kappa B; Phenols; Polyphenols; Prostatic Neoplasms; Reactive Oxygen Species	2007
Copper control as an antiangiogenic anticancer therapy: lessons from treating Wilson's disease. Experimental biology and medicine (Maywood, N.J.), 2001, Volume: 226, Issue:7 Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Copper; Hepatolenticular Degeneration; Humans; Molybdenum; Neoplasms; Zinc	2001
Progress in applied chemoprevention research. Seminars in oncology, 1990, Volume: 17, Issue:4 Topics: Animals; Antineoplastic Agents; Dehydroepiandrosterone; Drug Evaluation; Eflornithine; Fenretinide; Humans; Molybdenum; Neoplasms; Piroxicam; Tretinoin	1990
Biosynthesis and metabolism of tetrahydrobiopterin and molybdopterin. Annual review of biochemistry, 1985, Volume: 54 Topics: Alcohol Oxidoreductases; Animals; Biopterins; Body Fluids; Coenzymes; GTP Cyclohydrolase; Humans; Immune System Diseases; Mental Disorders; Metalloproteins; Molybdenum; Molybdenum Cofactors; Neoplasms; Nervous System Diseases; Phenylalanine; Phenylketonurias; Pteridines; Pterins; Tetrahydrofolate Dehydrogenase; Tissue Distribution; Tryptophan Hydroxylase; Tyrosine 3-Monooxygenase	1985
Trace elements in human milk, selenium a case study. The Science of the total environment, 1985, Mar-15, Volume: 42, Issue:1-2 Topics: Arsenic; Chromium; Cobalt; Copper; Female; Heart Diseases; Humans; Iron; Longitudinal Studies; Manganese; Milk, Human; Molybdenum; Neoplasms; Parenteral Nutrition, Total; Pregnancy; Selenium; Trace Elements; Zinc	1985

Trials

4 trial(s) available for molybdenum and Neoplasms

Article	Year
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors. Annales medico-psychologiques, 2021, Volume: 179, Issue:2 Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses	2021
Phase I study of copper-binding agent ATN-224 in patients with advanced solid tumors. Clinical cancer research : an official journal of the American Association for Cancer Research, 2008, Nov-15, Volume: 14, Issue:22 Topics: Adult; Aged; Ceruloplasmin; Chelating Agents; Chelation Therapy; Choline; Copper; Cytokines; Endothelial Cells; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Molybdenum; Neoplasms; Superoxide Dismutase	2008
Total and cancer mortality after supplementation with vitamins and minerals: follow-up of the Linxian General Population Nutrition Intervention Trial. Journal of the National Cancer Institute, 2009, Apr-01, Volume: 101, Issue:7 Topics: Adult; Age Factors; Aged; Aged, 80 and over; alpha-Tocopherol; Antioxidants; Ascorbic Acid; beta Carotene; China; Confounding Factors, Epidemiologic; Dietary Supplements; Diterpenes; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Malnutrition; Micronutrients; Middle Aged; Molybdenum; Neoplasms; Niacin; Odds Ratio; Retinyl Esters; Riboflavin; Risk Factors; Selenium; Vitamin A; Vitamins; Zinc Oxide	2009
Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: Phase I study. Clinical cancer research : an official journal of the American Association for Cancer Research, 2000, Volume: 6, Issue:1 Topics: Adult; Angiogenesis Inhibitors; Animals; Biomarkers; Ceruloplasmin; Copper; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Mice; Middle Aged; Molybdenum; Neoplasm Metastasis; Neoplasms	2000

Other Studies

80 other study(ies) available for molybdenum and Neoplasms

Article	Year
MoS Talanta, 2022, Feb-01, Volume: 238, Issue:Pt 2 Topics: Biomarkers, Tumor; Biosensing Techniques; Electrochemical Techniques; Gold; Humans; Limit of Detection; Metal Nanoparticles; MicroRNAs; Molybdenum; Neoplasms; Titanium	2022
Enhancing Tumor Catalytic Therapy by Co-Catalysis. Angewandte Chemie (International ed. in English), 2022, 04-19, Volume: 61, Issue:17 Topics: Catalysis; Humans; Hydrogen Peroxide; Molybdenum; Neoplasms; Oxidation-Reduction	2022
Development of a magnetic MoS Colloids and surfaces. B, Biointerfaces, 2022, Volume: 213 Topics: Animals; Cell Line, Tumor; Doxorubicin; Drug Liberation; Humans; Hyperthermia, Induced; Lipids; Magnetic Phenomena; Mice; Molybdenum; Nanoparticles; Neoplasms; Phototherapy	2022
Synthetic and Biodegradable Molybdenum(IV) Diselenide Triggers the Cascade Photo- and Immunotherapy of Tumor. Advanced healthcare materials, 2022, Volume: 11, Issue:15 Topics: Catalase; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Humans; Immunotherapy; Molybdenum; Nanoparticles; Neoplasms; Photochemotherapy; Photosensitizing Agents; Porphyrins; Tumor Microenvironment	2022
NIR-II Responsive Molybdenum Dioxide Nanosystem Manipulating Cellular Immunogenicity for Enhanced Tumor Photoimmunotherapy. Nano letters, 2022, 06-22, Volume: 22, Issue:12 Topics: Cell Line, Tumor; Humans; Immunotherapy; Molybdenum; Nanoparticles; Neoplasms; Oxides; Phototherapy	2022
Injectable and Self-Healing Polysaccharide Hydrogel Loading Molybdenum Disulfide Nanoflakes for Synergistic Photothermal-Photodynamic Therapy of Breast Cancer. Macromolecular bioscience, 2022, Volume: 22, Issue:9 Topics: Disulfides; Humans; Hydrogels; Molybdenum; Nanogels; Neoplasms; Photochemotherapy; Phototherapy; Polysaccharides; Serum Albumin, Bovine	2022
MoS Biomaterials, 2022, Volume: 290 Topics: Animals; Catalysis; Cell Line, Tumor; Doxorubicin; Mice; Molybdenum; Nanomedicine; Nanoparticles; Neoplasms; Water	2022
Piezo-Activated Atomic-Thin Molybdenum Disulfide/MXene Nanoenzyme for Integrated and Efficient Tumor Therapy via Ultrasound-Triggered Schottky Electric Field. Small (Weinheim an der Bergstrasse, Germany), 2023, Volume: 19, Issue:9 Topics: Chitosan; Humans; Molybdenum; Neoplasms; Tumor Microenvironment	2023
Oxygen-Deficient Molybdenum Oxide Nanosensitizers for Ultrasound-Enhanced Cancer Metalloimmunotherapy. Angewandte Chemie (International ed. in English), 2023, 02-20, Volume: 62, Issue:9 Topics: Cell Line, Tumor; Humans; Hypoxia; Molybdenum; Neoplasms; Oxides; Oxygen; Reactive Oxygen Species	2023
A single-step plasma method for rapid production of 2D, ferromagnetic, surface vacancy-engineered MoO Nanotechnology, 2023, Feb-21, Volume: 34, Issue:19 Topics: Animals; Humans; Mice; Molybdenum; Nanostructures; Neoplasms; Oxides; Phototherapy	2023
Photothermal Attenuation of Cancer Cell Stemness, Chemoresistance, and Migration Using CD44-Targeted MoS Nano letters, 2023, 03-08, Volume: 23, Issue:5 Topics: Antineoplastic Agents; Cell Differentiation; Cell Line, Tumor; Drug Resistance, Neoplasm; Molybdenum; Neoplasms	2023
Photo-/piezo-activated ultrathin molybdenum disulfide nanomedicine for synergistic tumor therapy. Journal of materials chemistry. B, 2023, 03-30, Volume: 11, Issue:13 Topics: Humans; Molybdenum; Nanomedicine; Neoplasms; Phototherapy	2023
Vacancy Augmented Piezo-Sonosensitizer for Cancer Therapy. Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2023, Volume: 10, Issue:26 Topics: Humans; Molybdenum; Neoplasms; Reactive Oxygen Species; Ultrasonic Therapy	2023
Construction of electrochemical biosensors based on MoSe Bioelectrochemistry (Amsterdam, Netherlands), 2023, Volume: 154 Topics: Animals; Biomarkers, Tumor; Biosensing Techniques; Electrochemical Techniques; Limit of Detection; Mice; MicroRNAs; Molybdenum; Neoplasms; Reproducibility of Results	2023
Quantitative measurement of CA 15-3 cancer biomarker using an electrochemical aptasensor based on the electrodeposition of Au thin film on cauliflower-like rGO-MoS Mikrochimica acta, 2023, 09-20, Volume: 190, Issue:10 Topics: Biomarkers, Tumor; Electroplating; Humans; Molybdenum; Mucin-1; Nanocomposites; Neoplasms; Oligonucleotides	2023
Porous Molybdenum Nitride Nanosphere as Carrier-Free and Efficient Nitric Oxide Donor for Synergistic Nitric Oxide and Chemo/Sonodynamic Therapy. ACS nano, 2023, 10-24, Volume: 17, Issue:20 Topics: Cell Line, Tumor; Humans; Molybdenum; Nanospheres; Neoplasms; Nitric Oxide; Nitric Oxide Donors; Porosity; Reactive Oxygen Species; Tumor Microenvironment; Ultrasonic Therapy	2023
Controllable growth of Au nanostructures onto MoS Nanoscale, 2019, Dec-21, Volume: 11, Issue:47 Topics: Animals; Cell Line, Tumor; Electrochemistry; Female; Gold; Hyperthermia, Induced; Light; Metal Nanoparticles; Mice; Mice, Inbred BALB C; Molybdenum; Nanostructures; Nanotechnology; Neoplasm Transplantation; Neoplasms; Oxygen; Photoacoustic Techniques; Photochemistry; Phototherapy; Polymers; Spectrophotometry, Infrared; Surface Properties; Theranostic Nanomedicine; Tomography, X-Ray Computed; X-Rays	2019
Glutathione Depletion in a Benign Manner by MoS Small (Weinheim an der Bergstrasse, Germany), 2019, Volume: 15, Issue:51 Topics: Cell Line, Tumor; Disulfides; Free Radicals; Glutathione; Humans; Molybdenum; Neoplasms; Polyethylene Glycols; Reactive Oxygen Species	2019
Layered MoS Colloids and surfaces. B, Biointerfaces, 2020, Volume: 187 Topics: Animals; Antineoplastic Agents; Biomimetic Materials; Cell Death; Cell Survival; Combined Modality Therapy; Disulfides; Doxorubicin; Drug Liberation; Humans; Hyperthermia, Induced; MCF-7 Cells; Mice, Inbred ICR; Molybdenum; Nanoparticles; Neoplasms; Phospholipids; Phototherapy; Serum Albumin, Bovine; Spectroscopy, Fourier Transform Infrared	2020
Spontaneous reduction of KMnO The Analyst, 2020, Feb-03, Volume: 145, Issue:3 Topics: Animals; Aptamers, Nucleotide; Biocompatible Materials; Cell Line, Tumor; Cell Survival; Disulfides; Glutathione; Humans; Magnetic Resonance Imaging; Mice; Mice, Inbred BALB C; Molybdenum; Neoplasms; Oxidation-Reduction; Potassium Permanganate; Quantum Dots	2020
A bioconjugated MoS Biomaterials science, 2020, Mar-31, Volume: 8, Issue:7 Topics: Antibodies, Monoclonal; Antigens, Neoplasm; Carbonic Anhydrase IX; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disulfides; Flow Cytometry; Humans; Molybdenum; Nanostructures; Neoplasms	2020
A simple POM clusters for in vivo NIR-II photoacoustic imaging-guided NIR-II photothermal therapy. Journal of inorganic biochemistry, 2020, Volume: 209 Topics: Animals; Anions; Cell Line, Tumor; Humans; Infrared Rays; Mice; Molybdenum; Nanoparticles; Neoplasms; Photoacoustic Techniques; Photothermal Therapy; Polyelectrolytes; Theranostic Nanomedicine	2020
Cancer Pro-oxidant Therapy Through Copper Redox Cycling: Current pharmaceutical design, 2020, Volume: 26, Issue:35 Topics: Cell Line, Tumor; Copper; Disulfiram; Drug Repositioning; Humans; Hydrogen Peroxide; Molybdenum; Neoplasms; Oxidation-Reduction; Reactive Oxygen Species	2020
MoS Colloids and surfaces. B, Biointerfaces, 2020, Volume: 195 Topics: Cell Line, Tumor; Glucose Oxidase; Humans; Hydrogels; Hydrogen Peroxide; Molybdenum; Neoplasms	2020
Multimode Imaging-Guided Photothermal/Chemodynamic Synergistic Therapy Nanoagent with a Tumor Microenvironment Responded Effect. ACS applied materials & interfaces, 2020, Nov-25, Volume: 12, Issue:47 Topics: Animals; Biocompatible Materials; Cell Line; Cell Survival; Contrast Media; Glutathione; Humans; Hydrogen Peroxide; Mice; Molybdenum; Multimodal Imaging; Nanoparticles; Neoplasms; Oxides; Photochemotherapy; Photothermal Therapy; Polyethylene Glycols; Porosity; Silicon Dioxide; Singlet Oxygen; Tumor Microenvironment	2020
An Electrochemical Sensor Based on Chalcogenide Molybdenum Disulfide-Gold-Silver Nanocomposite for Detection of Hydrogen Peroxide Released by Cancer Cells. Sensors (Basel, Switzerland), 2020, Nov-28, Volume: 20, Issue:23 Topics: Disulfides; Electrochemical Techniques; Gold; Hydrogen Peroxide; Limit of Detection; Molybdenum; Nanocomposites; Neoplasms; Silver	2020
Coupling metal organic frameworks with molybdenum disulfide nanoflakes for targeted cancer theranostics. Biomaterials science, 2021, May-04, Volume: 9, Issue:9 Topics: Cell Line, Tumor; Disulfides; Doxorubicin; Drug Delivery Systems; Drug Liberation; Metal-Organic Frameworks; Molybdenum; Nanoparticles; Neoplasms; Phototherapy; Precision Medicine; Theranostic Nanomedicine	2021
2D LDH-MoS Journal of nanobiotechnology, 2021, Feb-03, Volume: 19, Issue:1 Topics: Animals; Biomimetic Materials; Catalase; Chlorophyllides; Disulfides; HT29 Cells; Humans; Hydroxides; Magnetic Resonance Imaging; Mice; Molybdenum; Nanostructures; Neoplasms; Photochemotherapy; Photosensitizing Agents; Photothermal Therapy; Porphyrins; Reactive Oxygen Species; Theranostic Nanomedicine	2021
NIPAM/PEG/ MoS2 Nanosheets for Dual Triggered Doxorubicin Release and Combined Chemo-photothermal Cancer Therapy. Current drug delivery, 2021, Volume: 18, Issue:9 Topics: Cell Survival; Doxorubicin; Drug Liberation; Humans; Molybdenum; Neoplasms; Photothermal Therapy; Polyethylene Glycols	2021
Defect Engineering Enables Synergistic Action of Enzyme-Mimicking Active Centers for High-Efficiency Tumor Therapy. Journal of the American Chemical Society, 2021, 06-16, Volume: 143, Issue:23 Topics: Humans; Iron; Lasers; Molybdenum; Neoplasms; Oxidation-Reduction; Oxides; Particle Size	2021
Customized Photothermal Therapy of Subcutaneous Orthotopic Cancer by Multichannel Luminescent Nanocomposites. Advanced materials (Deerfield Beach, Fla.), 2021, Volume: 33, Issue:30 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Disease Models, Animal; Glutathione; Humans; Infrared Rays; Lanthanoid Series Elements; Luminescent Agents; Metal Nanoparticles; Mice; Molybdenum; Nanocomposites; Neoplasms; Photothermal Therapy; Silicon Compounds; Surface Properties; Theranostic Nanomedicine	2021
Intelligent Molybdenum Disulfide Complexes as a Platform for Cooperative Imaging-Guided Tri-Mode Chemo-Photothermo-Immunotherapy. Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2021, Volume: 8, Issue:14 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Combined Modality Therapy; Disease Models, Animal; Disulfides; Immunotherapy; Mice; Molybdenum; Nanoparticle Drug Delivery System; Neoplasms; Photoacoustic Techniques; Phototherapy; Radiography, Interventional; Tomography, X-Ray Computed	2021
Co-Delivery of Doxorubicin and Chloroquine by Polyglycerol Functionalized MoS2 Nanosheets for Efficient Multidrug-Resistant Cancer Therapy. Macromolecular bioscience, 2021, Volume: 21, Issue:11 Topics: Chloroquine; Disulfides; Doxorubicin; Drug Resistance, Neoplasm; Glycerol; HeLa Cells; Humans; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Molybdenum; Nanostructures; Neoplasms; Polymers; Spectrophotometry, Ultraviolet	2021
Multifunctional Nanosystem for Synergistic Tumor Therapy Delivered by Two-Dimensional MoS ACS applied materials & interfaces, 2017, Apr-26, Volume: 9, Issue:16 Topics: Disulfides; Humans; Molybdenum; Nanostructures; Neoplasms; Photochemotherapy; Photosensitizing Agents; Phototherapy; Tolonium Chloride	2017
Carcinogenicity of welding, molybdenum trioxide, and indium tin oxide. The Lancet. Oncology, 2017, Volume: 18, Issue:5 Topics: Animals; Carcinogens, Environmental; Humans; Molybdenum; Neoplasms; Occupational Exposure; Occupational Health; Oxides; Risk Assessment; Tin Compounds; Welding	2017
CpG loaded MoS Nanoscale, 2017, May-11, Volume: 9, Issue:18 Topics: Animals; Cell Line, Tumor; CpG Islands; Immunotherapy; Mice; Mice, Inbred C57BL; Molybdenum; Nanoconjugates; Neoplasms; Phototherapy; RAW 264.7 Cells	2017
Antimonene Quantum Dots: Synthesis and Application as Near-Infrared Photothermal Agents for Effective Cancer Therapy. Angewandte Chemie (International ed. in English), 2017, 09-18, Volume: 56, Issue:39 Topics: Animals; Biocompatible Materials; Cell Line, Tumor; Disulfides; Gold; Graphite; Humans; Infrared Rays; Mice; Mice, Nude; Molybdenum; Neoplasms; Phosphorus; Phototherapy; Polyethylene Glycols; Quantum Dots; Spectrum Analysis; Surface Properties; Xenograft Model Antitumor Assays	2017
Phase and morphological control of MoO Nanoscale, 2017, Aug-10, Volume: 9, Issue:31 Topics: Animals; Cell Line, Tumor; Humans; Hydrophobic and Hydrophilic Interactions; Mice; Molybdenum; Nanostructures; Neoplasms; Oxides; Oxygen; Phototherapy; Theranostic Nanomedicine	2017
Neutron-activatable needles for radionuclide therapy of solid tumors. Journal of biomedical materials research. Part A, 2017, Volume: 105, Issue:12 Topics: Brachytherapy; Coated Materials, Biocompatible; Drug Delivery Systems; Equipment Design; Holmium; Humans; Molybdenum; Needles; Neoplasms; Neutrons; Rhenium; Titanium; Transdermal Patch	2017
Intracellular Mechanistic Understanding of 2D MoS ACS nano, 2018, 03-27, Volume: 12, Issue:3 Topics: Animals; Antibiotics, Antineoplastic; Autophagy; Disulfides; Doxorubicin; Endocytosis; Exocytosis; HeLa Cells; Humans; Lysosomes; MCF-7 Cells; Mice, Inbred BALB C; Molybdenum; Nanostructures; Neoplasms	2018
Bimetallic Oxide MnMoO Nano letters, 2018, 09-12, Volume: 18, Issue:9 Topics: Animals; Glutathione; Hyperthermia, Induced; Manganese Compounds; Mice; Molybdenum; Nanotubes; Neoplasms; Oxides; Photoacoustic Techniques; Phototherapy; Theranostic Nanomedicine; Tumor Microenvironment	2018
From Photoinduced to Dark Cytotoxicity through an Octahedral Cluster Hydrolysis. Chemistry (Weinheim an der Bergstrasse, Germany), 2018, Dec-05, Volume: 24, Issue:68 Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Drug Stability; Hep G2 Cells; Humans; Hydrolysis; Light; Models, Molecular; Molybdenum; Neoplasms; Photochemical Processes; Photosensitizing Agents; Tungsten	2018
Synergistic Nanozymetic Activity of Hybrid Gold Bipyramid-Molybdenum Disulfide Core@Shell Nanostructures for Two-Photon Imaging and Anticancer Therapy. ACS applied materials & interfaces, 2018, Dec-12, Volume: 10, Issue:49 Topics: Cell Line, Tumor; Disulfides; Gold; Humans; Microscopy, Fluorescence, Multiphoton; Molybdenum; Nanoparticles; Neoplasms; Photochemotherapy	2018
A novel magnetic fluorescent biosensor based on graphene quantum dots for rapid, efficient, and sensitive separation and detection of circulating tumor cells. Analytical and bioanalytical chemistry, 2019, Volume: 411, Issue:5 Topics: A549 Cells; Aptamers, Nucleotide; Biosensing Techniques; Cell Separation; Disulfides; Epithelial Cell Adhesion Molecule; Equipment Design; Ferrosoferric Oxide; Fluorescent Dyes; Graphite; HEK293 Cells; Hep G2 Cells; Humans; Molybdenum; Nanostructures; Neoplasms; Neoplastic Cells, Circulating; Quantum Dots	2019
Tetrathiomolybdate induces dimerization of the metal-binding domain of ATPase and inhibits platination of the protein. Nature communications, 2019, 01-14, Volume: 10, Issue:1 Topics: Antineoplastic Agents; Chelating Agents; Cisplatin; Copper; Copper-Transporting ATPases; Cross-Linking Reagents; Crystallography, X-Ray; Cysteine; Drug Resistance, Neoplasm; Drug Synergism; Enzyme Inhibitors; Humans; Molybdenum; Neoplasms; Platinum; Protein Interaction Domains and Motifs; Protein Multimerization; Protein Structure, Secondary	2019
Ultrasmall MoS ACS applied materials & interfaces, 2019, Feb-13, Volume: 11, Issue:6 Topics: Animals; Cell Line, Tumor; Cell Survival; Chlorophyllides; Disulfides; Humans; Hyaluronic Acid; Mice; Microscopy, Confocal; Molybdenum; Multimodal Imaging; Nanocomposites; Nanoparticles; Neoplasms; Photochemotherapy; Photosensitizing Agents; Phototherapy; Porphyrins; Quantum Dots; Silicon Dioxide; Singlet Oxygen; Transplantation, Heterologous	2019
Remote Induction of Cell Autophagy by 2D MoS ACS applied materials & interfaces, 2019, Feb-20, Volume: 11, Issue:7 Topics: Autophagy; Cell Line, Tumor; Disulfides; Humans; Molybdenum; Nanoparticles; Neoplasm Proteins; Neoplasms; Receptors, Cell Surface; Signal Transduction; TOR Serine-Threonine Kinases	2019
Molybdenum disulfide-integrated photonic barcodes for tumor markers screening. Biosensors & bioelectronics, 2019, May-15, Volume: 133 Topics: Biomarkers, Tumor; Biosensing Techniques; Colloids; Disulfides; Humans; Limit of Detection; MicroRNAs; Molybdenum; Neoplasms; Photons; Quantum Dots; Silicon Dioxide	2019
Redox/NIR dual-responsive MoS Journal of nanobiotechnology, 2019, Jul-03, Volume: 17, Issue:1 Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Cell Line, Tumor; Cell Survival; Combined Modality Therapy; Disulfides; Drug Carriers; Drug Liberation; Female; Fluorescent Dyes; Humans; Hyaluronic Acid; Hyperthermia, Induced; Infrared Rays; Mice, Nude; Molybdenum; Nanoparticles; Neoplasm Transplantation; Neoplasms; Oxidation-Reduction; Photochemotherapy	2019
A dual-mode nanoprobe for evaluation of the autophagy level affected by photothermal therapy. Chemical communications (Cambridge, England), 2019, Aug-21, Volume: 55, Issue:65 Topics: Aptamers, Nucleotide; Autophagy; Carbocyanines; Down-Regulation; Fluorescent Dyes; Humans; Hyperthermia, Induced; Limit of Detection; MCF-7 Cells; MicroRNAs; Molybdenum; Nanospheres; Neoplasms; Nucleic Acid Hybridization; Oxides; Particle Size; Phototherapy; Spectrometry, Fluorescence; Spectrum Analysis, Raman	2019
Hydrophilic molybdenum oxide nanomaterials with controlled morphology and strong plasmonic absorption for photothermal ablation of cancer cells. ACS applied materials & interfaces, 2014, Mar-26, Volume: 6, Issue:6 Topics: Absorption; Cell Line, Tumor; Humans; Hydrophobic and Hydrophilic Interactions; Laser Therapy; Molybdenum; Nanostructures; Neoplasms; Oxides; Surface Plasmon Resonance	2014
["Technetium crisis" - causes, possible solutions and consequences for planar scintigraphy and SPECT diagnostics]. Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti, 2014, Volume: 27 Suppl 1 Topics: Humans; Molybdenum; Neoplasms; Radioisotopes; Radiopharmaceuticals; Technetium; Tomography, Emission-Computed, Single-Photon	2014
MoS₂ exhibits stronger toxicity with increased exfoliation. Nanoscale, 2014, Nov-06, Volume: 6, Issue:23 Topics: Antineoplastic Agents; Cell Line, Tumor; Disulfides; Humans; Molybdenum; Nanoparticles; Neoplasms	2014
Two novel compounds of vanadium and molybdenum with carnitine exhibiting potential pharmacological use. Journal of inorganic biochemistry, 2015, Volume: 142 Topics: A549 Cells; Animals; Antineoplastic Agents; Carnitine; Coordination Complexes; Drug Screening Assays, Antitumor; Humans; Mice; Molybdenum; Neoplasms; Vanadium	2015
A Facile One-Pot Synthesis of a Two-Dimensional MoS2 /Bi2S3 Composite Theranostic Nanosystem for Multi-Modality Tumor Imaging and Therapy. Advanced materials (Deerfield Beach, Fla.), 2015, May-06, Volume: 27, Issue:17 Topics: Animals; Bismuth; Cell Line, Tumor; Contrast Media; Disulfides; Humans; Infrared Rays; Mice; Mice, Nude; Molybdenum; Nanostructures; Neoplasms; Phototherapy; Polyethylene Glycols; Sulfides; Survival Rate; Theranostic Nanomedicine; Tissue Distribution; Tomography, X-Ray Computed	2015
Smart MoS2/Fe3O4 Nanotheranostic for Magnetically Targeted Photothermal Therapy Guided by Magnetic Resonance/Photoacoustic Imaging. Theranostics, 2015, Volume: 5, Issue:9 Topics: Animals; Disease Models, Animal; Disulfides; Drug Delivery Systems; Ferric Compounds; HeLa Cells; Hep G2 Cells; Humans; Hyperthermia, Induced; Infrared Rays; Magnetic Resonance Imaging; Male; Mice, Inbred BALB C; Molybdenum; Nanoparticles; Neoplasms; Photoacoustic Techniques; Theranostic Nanomedicine; Treatment Outcome	2015
Graphene-like two-dimensional layered nanomaterials: applications in biosensors and nanomedicine. Nanoscale, 2015, Sep-14, Volume: 7, Issue:34 Topics: Animals; Biosensing Techniques; Boron Compounds; Cell Line, Tumor; Cell Survival; Disulfides; Drug Carriers; Electrochemical Techniques; Graphite; Humans; Mice; Molybdenum; Nanomedicine; Nanostructures; Neoplasms; Nitriles; Polyethylene Glycols; Tomography, X-Ray Computed	2015
Reusable and dual-potential responses electrogenerated chemiluminescence biosensor for synchronously cytosensing and dynamic cell surface N-glycan evaluation. Analytical chemistry, 2015, Oct-06, Volume: 87, Issue:19 Topics: Aptamers, Nucleotide; Biosensing Techniques; Cell Line, Tumor; Cell Membrane; Disulfides; Equipment Design; Humans; Luminescence; Luminescent Agents; Luminescent Measurements; Molybdenum; Nanostructures; Neoplasms; Organometallic Compounds; Phenanthrolines; Polysaccharides	2015
Injectable 2D MoS2 -Integrated Drug Delivering Implant for Highly Efficient NIR-Triggered Synergistic Tumor Hyperthermia. Advanced materials (Deerfield Beach, Fla.), 2015, Nov-25, Volume: 27, Issue:44 Topics: Animals; Cell Line; Disulfides; Doxorubicin; Drug Carriers; Hyperthermia, Induced; Infrared Rays; Injections; Lactic Acid; Lasers; Mice; Models, Molecular; Molecular Conformation; Molybdenum; Neoplasms; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Prostheses and Implants	2015
Tetrathiomolybdate inhibits mitochondrial complex IV and mediates degradation of hypoxia-inducible factor-1α in cancer cells. Scientific reports, 2015, Oct-15, Volume: 5 Topics: Cell Line, Tumor; Cell Respiration; Electron Transport Complex IV; Gene Expression Regulation, Neoplastic; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Molybdenum; Neoplasms; Oxygen; Phosphatidylinositol 3-Kinases; Proteolysis; Proto-Oncogene Proteins c-akt; Signal Transduction	2015
One-pot synthesis of PEGylated plasmonic MoO(3-x) hollow nanospheres for photoacoustic imaging guided chemo-photothermal combinational therapy of cancer. Biomaterials, 2016, Volume: 76 Topics: Animals; Antineoplastic Agents; Combined Modality Therapy; HeLa Cells; Humans; Hyperthermia, Induced; Mice; Mice, Inbred BALB C; Mice, Nude; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Molybdenum; Nanospheres; Neoplasms; Oxides; Phototherapy; Polyethylene Glycols	2016
Aqueous phase preparation of ultrasmall MoSe2 nanodots for efficient photothermal therapy of cancer cells. Nanoscale, 2016, Feb-07, Volume: 8, Issue:5 Topics: Cell Survival; HeLa Cells; Humans; Infrared Rays; Microscopy, Electron, Transmission; Molybdenum; Nanoparticles; Neoplasms; Photoelectron Spectroscopy; Phototherapy; Polymers; Selenium; Water; X-Ray Diffraction	2016
Single-layer MoS2 nanosheet grafted upconversion nanoparticles for near-infrared fluorescence imaging-guided deep tissue cancer phototherapy. Nanoscale, 2016, Apr-21, Volume: 8, Issue:15 Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Disulfides; Female; Humans; Infrared Rays; Metal Nanoparticles; Mice; Mice, Nude; Molybdenum; Nanotechnology; Neoplasms; Optical Imaging; Phototherapy; Xenograft Model Antitumor Assays	2016
Enhancing tumor-specific uptake of the anticancer drug cisplatin with a copper chelator. Cancer cell, 2010, Jun-15, Volume: 17, Issue:6 Topics: Adenosine Triphosphatases; Adjuvants, Pharmaceutic; Adult; Aged; Aged, 80 and over; Animal Structures; Animals; Carboplatin; Cation Transport Proteins; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chelating Agents; Cisplatin; Copper; Copper Transporter 1; Copper-Transporting ATPases; Disease Models, Animal; Disease-Free Survival; DNA Adducts; Female; Gene Expression; Humans; Mice; Mice, Inbred Strains; Middle Aged; Molybdenum; Neoplasms; Neovascularization, Pathologic; Ovarian Neoplasms; Treatment Outcome; Uterine Cervical Neoplasms	2010
Mo(II) complexes: a new family of cytotoxic agents? Journal of inorganic biochemistry, 2010, Volume: 104, Issue:11 Topics: 1-Octanol; Antineoplastic Agents; Breast Neoplasms; Cell Death; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; HeLa Cells; Humans; Inhibitory Concentration 50; Molecular Structure; Molybdenum; Neoplasms; Neuroblastoma; Nucleic Acid Conformation; Phenanthrolines; Tetrazolium Salts; Thiazoles; Water	2010
Copper chelation enhances antitumor efficacy and systemic delivery of oncolytic HSV. Clinical cancer research : an official journal of the American Association for Cancer Research, 2012, Sep-15, Volume: 18, Issue:18 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Chelating Agents; Combined Modality Therapy; Copper; Cytopathogenic Effect, Viral; Female; Genetic Therapy; Genetic Vectors; Glioma; Humans; Mice; Mice, Nude; Molybdenum; Neoplasms; Oncolytic Virotherapy; Oncolytic Viruses; Simplexvirus; Virus Replication; Xenograft Model Antitumor Assays	2012
The need for selenite and molybdate in the formation of formic dehydrogenase by members of the coli-aerogenes group of bacteria. The Biochemical journal, 1954, Volume: 57, Issue:1 Topics: Aldehyde Oxidoreductases; Bacteria; Breast Neoplasms; Enterobacter aerogenes; Escherichia coli; Molybdenum; Neoplasms; Oxidoreductases; Selenious Acid; Selenium; Selenium Compounds	1954
Further observations on the action of preparations of phosphotungstic and phosphomolybdic acids upon cancer. Journal of the Indian Medical Association, 1954, Volume: 23, Issue:8 Topics: Breast Neoplasms; Humans; Male; Molybdenum; Neoplasms; Penile Neoplasms; Penis; Phosphoric Acids; Tungsten	1954
PRELIMINARY PHYSIOLOGICAL STUDIES OF MOLYBDENUM (MO99) IN LIVER SCANNING. Radiology, 1964, Volume: 82 Topics: Humans; Liver; Liver Diseases; Molybdenum; Neoplasms; Radioisotopes; Radionuclide Imaging	1964
TREATMENT OF CANCER OF THE INTESTINAL TRACT WITH A COMPLEX COMPOUND OF PHOSPHOTUNGSTIC PHOSPHOMOLYBDIC ACIDS AND CAFFEINE. Journal of the Indian Medical Association, 1965, May-01, Volume: 44 Topics: Antineoplastic Agents; Caffeine; Geriatrics; Humans; Intestinal Neoplasms; Molybdenum; Neoplasms; Phosphoric Acids; Phosphotungstic Acid	1965
Action of preparations of phosphotungstic and phosphomolybdic acids on cancer. Journal of the Indian Medical Association, 1952, Volume: 21, Issue:7 Topics: Genitalia; Genitalia, Male; Humans; Molybdenum; Neoplasms; Phosphoric Acids; Tungsten	1952
Chemotherapy of cancer with phosphotungstic acid-H2O2 and phosphomolybdic acid-H2O2 preparations. Journal of the Indian Medical Association, 1950, Volume: 19, Issue:8 Topics: Humans; Hydrogen Peroxide; Molybdenum; Neoplasms; Phosphoric Acids; Phosphotungstic Acid	1950
[Determination of trace Al in serum of cancer patients by graphite furnace atomic absorption spectrometry using K2Cr2O7 and surfactant as matrix modifier with molybdenate coated tubes]. Guang pu xue yu guang pu fen xi = Guang pu, 1998, Volume: 18, Issue:1 Topics: Aluminum; Blood Chemical Analysis; Graphite; Humans; Molybdenum; Neoplasms; Potassium Dichromate; Spectrophotometry, Atomic; Surface-Active Agents; Temperature	1998
Molybdenum. Monograph. Alternative medicine review : a journal of clinical therapeutic, 2006, Volume: 11, Issue:2 Topics: Animals; Coenzymes; Drug Hypersensitivity; Hepatolenticular Degeneration; Humans; Metalloproteins; Molybdenum; Molybdenum Cofactors; Neoplasms; Pteridines; Sulfites	2006
Comparison of lowering copper levels with tetrathiomolybdate and zinc on mouse tumor and doxorubicin models. Translational research : the journal of laboratory and clinical medicine, 2006, Volume: 148, Issue:6 Topics: Animals; Antibiotics, Antineoplastic; Ceruloplasmin; Copper; Creatine Kinase; Delayed-Action Preparations; Disease Models, Animal; Doxorubicin; Drug Antagonism; Heart; Instillation, Drug; L-Lactate Dehydrogenase; Male; Mice; Mice, Inbred C57BL; Molybdenum; Neoplasm Transplantation; Neoplasms; Troponin I; Zinc	2006
Molybdenum: an essential trace element. Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition, 1993, Volume: 8, Issue:6 Topics: Deficiency Diseases; Food Analysis; Humans; Metabolism, Inborn Errors; Molybdenum; Neoplasms; Trace Elements	1993
Cutting copper curbs angiogenesis, studies show. Journal of the National Cancer Institute, 2000, Aug-02, Volume: 92, Issue:15 Topics: Angiogenesis Inhibitors; Brain Neoplasms; Chelating Agents; Clinical Trials as Topic; Combined Modality Therapy; Copper; Glioblastoma; Humans; Molybdenum; Neoplasms; Neovascularization, Pathologic; Penicillamine	2000
Pilot studies on the effects of a phosphomolybdic tungstic acid compound (PTMC) on spontaneous malignant tumours in dogs. European journal of cancer & clinical oncology, 1988, Volume: 24, Issue:3 Topics: Animals; Antineoplastic Agents; Dog Diseases; Dogs; Molybdenum; Neoplasms; Organometallic Compounds; Tungsten	1988
An overview of distribution patterns of trace elements in soils and plants. Annals of the New York Academy of Sciences, 1972, Jun-28, Volume: 199 Topics: Dental Caries; Diet; Environmental Health; Geography; Geological Phenomena; Geology; Goiter; Humans; Iodine; Molybdenum; Morbidity; Neoplasms; Nutrition Disorders; Nutritional Requirements; Plants; Selenium; Soil; Trace Elements; United States	1972
[A new attempt at estimating the activity of the rheumatic process: the influence of urine on the reduction of the molybdates]. Polski tygodnik lekarski (Warsaw, Poland : 1960), 1970, Jun-22, Volume: 25, Issue:25 Topics: Arthritis, Rheumatoid; Female; Humans; Male; Methods; Molybdenum; Neoplasms; Osteoarthritis; Oxidation-Reduction; Pregnancy; Rheumatic Diseases; Spondylitis, Ankylosing	1970